Details for Patent: 5,102,665
✉ Email this page to a colleague
Summary for Patent: 5,102,665
Title: | Pharmaceutical compositions |
Abstract: | An effervescent pharmaceutical composition for oral use comprising ranitidine or a physiologically acceptable salt thereof, a monoalkali metal citrate, and an alkaline carbonate or bicarbonate. |
Inventor(s): | Schaeffer; Alain E. E. (Saint Sebastien de Morsent, FR) |
Assignee: | Glaxo Group Limited (London, GB2) |
Application Number: | 07/666,102 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; | More… ↓ |
Drugs Protected by US Patent 5,102,665
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,102,665
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
France | 88 08497 | Jun 24, 1988 |
International Family Members for US Patent 5,102,665
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 396426 | ⤷ Subscribe | |||
Austria | A154489 | ⤷ Subscribe | |||
Australia | 3674489 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |